Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR13604] to FAM160A2
- Suitable for: WB
- Reacts with: Human
Product nameAnti-FAM160A2 antibody [EPR13604]
See all FAM160A2 primary antibodies
DescriptionRabbit monoclonal [EPR13604] to FAM160A2
Tested applicationsSuitable for: WBmore details
Species reactivityReacts with: Human
Recombinant fragment within Human FAM160A2 aa 500-650. The exact sequence is proprietary.
Database link: Q8N612
- HeLa and Human fetal brain lysates.
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
Storage bufferPreservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol, 0.05% BSA
Concentration information loading...
PurityProtein A purified
Our Abpromise guarantee covers the use of ab184160 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/1000. Detects a band of approximately 106 kDa (predicted molecular weight: 106 kDa).|
FunctionComponent of the FTS/Hook/FHIP complex (FHF complex). The FHF complex may function to promote vesicle trafficking and/or fusion via the homotypic vesicular protein sorting complex (the HOPS complex).
Sequence similaritiesBelongs to the UPF0518 family.
- Information by UniProt
- C11orf56 antibody
- F16A2_HUMAN antibody
- FAM160A2 antibody
ab184160 has been referenced in 1 publication.
- Redwine WB et al. The human cytoplasmic dynein interactome reveals novel activators of motility. Elife 6:N/A (2017). PubMed: 28718761